Bicara Therapeutics, Inc. (BCAX)
14.99
-0.37
(-2.41%)
USD |
NASDAQ |
Feb 09, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
Bicara Therapeutics EPS Diluted (Quarterly) : -0.6658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncotelic Therapeutics, Inc. | -0.0025 |
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.33M |
| Total Expenses (Quarterly) | 36.33M |
| Enterprise Value | 532.99M |
| Earnings Yield | -14.87% |
| Normalized Earnings Yield | -14.87 |